Company Filing History:
Years Active: 2014-2024
Title: **Mehdi Arbabi-Ghahroudi: Innovator in Antibody Research**
Introduction
Mehdi Arbabi-Ghahroudi is a distinguished inventor based in Ottawa, Canada. He holds seven patents, showcasing his significant contributions to the field of biomedical research, particularly in the development of therapeutic antibodies.
Latest Patents
Among his latest inventions are two notable patents. The first patent focuses on antibodies and antibody fragments against the Na v.7 channel, specifically designed to alleviate pain and treat hyperproliferative diseases. The innovations detail the mechanism through which these antibodies can antagonize the Na v.7 polypeptide, offering potential solutions for pain management and cancer treatment. The second patent revolves around insulin-like growth factor 1 receptor (IGF 1R)-specific antibodies. This research addresses the challenge of molecule transport across the blood-brain barrier (BBB), utilizing receptor-mediated transcytosis to deliver therapeutic agents efficiently. These antibodies, derived from a camelid VHH immunized with a specific IGF 1R polypeptide, hold promise for enhancing drug delivery across one of the body's most vital barriers.
Career Highlights
Mehdi Arbabi-Ghahroudi is currently affiliated with the National Research Council of Canada, where he continues to advance research in immunology and therapeutics. His work not only expands the understanding of antibody functionality but also seeks practical applications in medicine.
Collaborations
Collaboration is a key aspect of Arbabi-Ghahroudi's research efforts. He works alongside notable colleagues in the field, including Danica Stanimirovic and Traian Sulea, with whom he shares valuable insights and breakthroughs in antibody innovation.
Conclusion
With a robust portfolio of patents and ongoing research, Mehdi Arbabi-Ghahroudi exemplifies the spirit of innovation in the biotechnology sector. His contributions to antibody development stand to impact the medical community significantly, offering new avenues for treating complex diseases.